Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris
Open Access
- 31 January 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 26 (5), 457-463
- https://doi.org/10.1093/eurheartj/ehi111
Abstract
Aims Serum levels of neopterin, an immune modulator secreted by activated macrophages, are elevated in patients with acute coronary syndromes compared with stable angina patients and control subjects. In unstable angina, serum neopterin levels correlate with the presence of vulnerable coronary stenosis, multiple complex coronary lesions, and patient outcome. The present study assessed the prognostic significance of raised serum neopterin concentrations in patients with stable angina pectoris. Methods and results We carried out a 1-year follow-up prospective study in 297 patients with chronic stable chest pain undergoing diagnostic coronary angiography. The primary study endpoint was the composite of non-fatal myocardial infarction, unstable angina, and cardiac death. Fifty-one patients (17.2%) had adverse coronary events during follow-up. Mean serum neopterin levels were significantly higher in patients with events compared with those without (P=0.02). On multiple regression analysis, neopterin levels (P=0.021), severity of coronary artery disease (P=0.009), and a history of previous myocardial infarction (P=0.001) were independent predictors of adverse events. Conclusions Serum neopterin is an independent predictor of major adverse coronary events in patients with chronic stable angina pectoris. This marker of macrophage activation may be useful for risk stratification in patients with chronic stable angina.Keywords
This publication has 31 references indexed in Scilit:
- Markers of Inflammation and Rapid Coronary Artery Disease Progression in Patients With Stable Angina PectorisCirculation, 2004
- Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromesHeart, 2004
- Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery diseaseThe American Journal of Cardiology, 2004
- Serum neopterin and complex stenosis morphology in patients with unstable anginaJournal of the American College of Cardiology, 2000
- Increased serum neopterin: a marker of coronary artery disease activity in womenHeart, 2000
- Serum neopterin in acute coronary syndromesThe Lancet, 1997
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.JCI Insight, 1994
- Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology.Circulation, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.The Journal of Experimental Medicine, 1984